331 related articles for article (PubMed ID: 29327910)
1. Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.
Vojnosanit Pregl; 2016 Oct; 73(10):927-33. PubMed ID: 29327910
[TBL] [Abstract][Full Text] [Related]
2. Partial Mesorectal Excision for Rectal Adenocarcinoma: Morbidity and Oncological Outcome.
Kanso F; Lefevre JH; Svrcek M; Chafai N; Parc Y; Tiret E
Clin Colorectal Cancer; 2016 Mar; 15(1):82-90.e1. PubMed ID: 26372333
[TBL] [Abstract][Full Text] [Related]
3. Cancer of the upper rectum.
Bondeven P
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697137
[TBL] [Abstract][Full Text] [Related]
4. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
Law WL; Chu KW
Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
[TBL] [Abstract][Full Text] [Related]
5. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
6. Local excision of T1 and T2 rectal cancer: proceed with caution.
Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M
Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of adenocarcinoma of the rectum.
Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
[TBL] [Abstract][Full Text] [Related]
8. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.
Feroci F; Vannucchi A; Bianchi PP; Cantafio S; Garzi A; Formisano G; Scatizzi M
World J Gastroenterol; 2016 Apr; 22(13):3602-10. PubMed ID: 27053852
[TBL] [Abstract][Full Text] [Related]
9. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
10. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
11. The relationship between mesorectal grading and oncological outcome in rectal adenocarcinoma.
Silva-Velazco J; Stocchi L; Valente MA; Church JM; Liska D; Gorgun E; Kalady MF; Kessler H; Steele SR; Delaney CP
Colorectal Dis; 2019 Mar; 21(3):315-325. PubMed ID: 30565830
[TBL] [Abstract][Full Text] [Related]
12. Mesorectal grades predict recurrences after curative resection for rectal cancer.
Maslekar S; Sharma A; Macdonald A; Gunn J; Monson JR; Hartley JE
Dis Colon Rectum; 2007 Feb; 50(2):168-75. PubMed ID: 17160574
[TBL] [Abstract][Full Text] [Related]
13. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
Kneist W; Heintz A; Wolf HK; Junginger T
Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
[TBL] [Abstract][Full Text] [Related]
14. The impact of total mesorectal excision in middle and low rectal carcinomas.
Tentes AA; Korakianitis OS; Veliovic D; Sgouridou E; Karagiozoglou C; Moustakas K
J BUON; 2010; 15(1):56-60. PubMed ID: 20414928
[TBL] [Abstract][Full Text] [Related]
15. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
16. Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.
Ferenschild FT; Dawson I; de Wilt JH; de Graaf EJ; Groenendijk RP; Tetteroo GW
Int J Colorectal Dis; 2009 Aug; 24(8):923-9. PubMed ID: 19488771
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence after mesorectal excision for rectal cancer.
Nesbakken A; Nygaard K; Westerheim O; Mala T; Lunde OC
Eur J Surg Oncol; 2002 Mar; 28(2):126-34. PubMed ID: 11884047
[TBL] [Abstract][Full Text] [Related]
18. Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.
Bushati M; Pucciarelli S; Gennaro N; Maretto I; Toppan P; Perin A; Urso EDL; Bagatella A; Spolverato G
Int J Colorectal Dis; 2019 Dec; 34(12):2129-2136. PubMed ID: 31724079
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal surgery and omission of neoadjuvant therapy for upper rectal cancer is associated with a high risk of local recurrence.
Bondeven P; Laurberg S; Hagemann-Madsen RH; Ginnerup Pedersen B
Colorectal Dis; 2015 Mar; 17(3):216-24. PubMed ID: 25510260
[TBL] [Abstract][Full Text] [Related]
20. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
